by Igen BioLab Group | Feb 25, 2020 | News
Checkpoint inhibitors have revolutionized cancer therapy but only work in a subset of patients and can lead to a multitude of toxicities, suggesting the need for more targeted delivery systems. Because of their preferential colonization of tumors, microbes are a...
by Igen BioLab Group | Feb 18, 2020 | News
Micro-organisms in the gut support healthy digestion by helping nerve cells within the intestine to regulate the contraction and relaxation of the muscle wall of the colon, according to new research from the Crick and Bern University. The study, published in Nature,...
by Igen BioLab Group | Feb 12, 2020 | News
Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that two prebiotics, mucin and inulin, slowed the growth of melanoma in mice by boosting the immune system’s ability to fight cancer. In contrast to probiotics, which are live...
by Igen BioLab Group | Jan 14, 2020 | News
More than a decade after the launch of the Human Microbiome Project, research in this field has grown exponentially, with studies associating microbial states or species with disorders including novel infectious etiologies and complex human disease. Scientists are...
by Igen BioLab Group | Jan 7, 2020 | News
The human microbiome has not only captured the attention of scientists, but also of health professionals and the lay press. Although initial studies focused on characterizing the intestinal microbiome in the context of health and disease and the influence of...
